Results 241 to 250 of about 31,151 (261)

Virus-Like Particles for Vaccine Development

2015
Over the last three decades, non-infective virus-like particles (VLP) that mimic the overall structure of viruses have become a widely accepted technology for developing diagnostic tools and therapy vectors, but especially for the construction of novel vaccines. Initially, VLPs were primarily derived from their corresponding viruses, and they proved to
openaire   +1 more source

Virus-like particle vaccines and adjuvants: the HPV paradigm

Expert Review of Vaccines, 2009
Franco M Buonaguro, Maria Lina Tornesello, Luigi Buonaguro   +2 more
exaly  

Monovalent virus-like particle vaccine protects guinea pigs and nonhuman primates against infection with multiple Marburg viruses

Expert Review of Vaccines, 2008
Dana L Swenson, Kelly L Warfield, Tom Larsen   +2 more
exaly  

AETIOLOGICAL ASSOCIATION OF A VIRUS-LIKE PARTICLE WITH ENTERICALLY TRANSMITTED NON-A, NON-B HEPATITIS

Lancet, The, 1988
Vidyā A Arankalle, John Ticehurst, Albert Z Kapikian   +2 more
exaly  

Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial

Lancet, The, 2004
Diane M Harper, Eduardo L Franco, Cosette Wheeler   +2 more
exaly  

Norovirus virus-like particle vaccines for the prevention of acute gastroenteritis

Expert Review of Vaccines, 2013
Charles Richardson, Paul M Mendelman
exaly  

Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial

Lancet, The, 2007
F Xavier Bosch, Paulo Naud, Jorge Salmeron   +2 more
exaly  

Dose sparing enabled by skin immunization with influenza virus-like particle vaccine using microneedles

Journal of Controlled Release, 2010
Fu-Shi Quan, Yeu-Chun Kim, Richard W Compans   +2 more
exaly  

Neuraminidase expressing virus-like particle vaccine provides effective cross protection against influenza virus

Virology, 2019
Ki-Hye Kim, Yu-Na Lee, Youri Lee
exaly  

Asymmetrical Flow Field-Flow Fractionation on Virus and Virus-Like Particle Applications

Microorganisms, 2019
Katri Eskelin, Minna M Poranen, Hanna M Oksanen   +2 more
exaly